Marcus on AI · Gary Marcus ·

Medvi, glorified by the NYT as a two-employee startup with $1B+ in revenue, is a warning about how AI can be misused for shady business and marketing practices

AI isn't the only thing behind Medvi

In this story Medvi NYT
Medvi, glorified by the NYT as a two-employee startup with $1B+ in revenue, is a warning about how AI can be misused for shady business and marketing practices

Lead Source

How this story grew

Coverage · 0 Discussion · 0
Apr 5Apr 7

More

Futurism: Futurism
MacRumors: MacRumors
Implicator.ai: Implicator.ai
The Decoder: The Decoder
voidzilla on YouTube: voidzilla on YouTube
Drug Discovery and Development: Drug Discovery and Development

Discussion

TechSnif Coverage

Medvi's $1B AI Hype Story Is a Cautionary Tale, Not a Victory

Gary Marcus warns that Medvi's viral NYT profile masks shady business practices enabled by AI hype.

A two-employee startup claiming over $1 billion in revenue sounds like the ultimate AI success story. The New York Times thought so too, publishing a glowing profile of Medvi that promptly went viral. The internet celebrated it as proof that AI can replace entire workforces.

Not so fast. AI researcher Gary Marcus is sounding the alarm. In a detailed breakdown on his blog, Marcus argues Medvi isn't the AI triumph it's been painted as. Instead, he says it's a textbook example of how AI hype can provide cover for questionable business and marketing practices.

The core issue: AI isn't the only thing powering Medvi's operation. Marcus contends the company's story was oversimplified and glorified, turning what should be a warning into a celebration.

The viral moment highlights a growing problem — uncritical AI cheerleading drowning out legitimate scrutiny of how these tools actually get deployed.